Ropes & Gray Advises Galderma in its Acquisition of Alastin Skincare

In The News
November 29, 2021

Ropes & Gray advised Galderma, one of the world’s largest independent dermatology companies, in its acquisition of Alastin Skincare, Inc. Terms of the transaction were not disclosed. The transaction was announced on Nov. 29 in a  press release. 

Galderma, present in approximately 100 countries, delivers an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care and Prescription Medicine. Alastin Skincare, founded in 2015, is the fastest-growing physician-dispensed skincare brand with innovative scientifically-proven and clinically-tested products. 

The Ropes & Gray team that advised Galderma was led by private equity partner Jim Davis (Chicago) and mergers & acquisitions partner Zachary Blume (Boston), and included labor, employment & benefits partner Jennifer Cormier (Boston), life sciences regulatory & compliance partner Kellie Combs (Washington, D.C.), tax partner Elaine B. Murphy (Boston), tax counsel Michael Mendelevich (Boston), litigation & enforcement partners Samer Musallam (Washington, D.C.), Brendan Hanifin and Timothy Farrell (both of Chicago) and Anne Johnson Palmer (San Francisco), private equity partner Neill Jakobe (Chicago), life sciences licensing partner Hannah Freeman (Boston), health care counsel Alison Fethke (Chicago), and litigation & enforcement counsel Steven Kaye (Boston) and Lisa Kaltenbrunner (London).